Melanoma and Redox Dynamics: A Crucial Tug-of-War in Tumor Onset and in Therapy Response
A special issue of Antioxidants (ISSN 2076-3921). This special issue belongs to the section "Health Outcomes of Antioxidants and Oxidative Stress".
Deadline for manuscript submissions: 31 May 2026 | Viewed by 852
Special Issue Editors
Interests: neuroblastoma; MYC amplification; cancer stemness; drug resistance; protein kinase C; oxidative stress; lipoperoxidation; apoptosis
Special Issues, Collections and Topics in MDPI journals
Interests: chemoresistance; cancer cell metabolism; stress adaptative cell response; cell death; redox homeostasis; redox signalling; antioxidants; glutathione
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cutaneous melanoma is among the best-known tumors induced by overproduction of Reactive Oxygen Species (ROS). Oxidative stress and redox homeostasis are involved in the onset of melanoma and its therapy resistance: oxidants promote cancer initiation and also counteract tumor spread, while antioxidants are involved in metastatization. In addition, melanoma adapt to oxidative conditions through the reprogramming of metabolism and the activation of antioxidant defenses and progressively acquires malignancy and metastatic potential.
Therefore, given the incidence and development of therapy resistance, identifying new melanoma "redox vulnerabilities" that could become effective therapeutic targets is a pressing priority. To achieve this goal, we must broaden our perspective and consider all the "competitors" participating in this "redox game". In particular, it is necessary to consider the intricate network of interactions between ROS, redox-modulated signaling pathways, redox-related transcription factors, mitochondria, cell response, as well as to understand the complexity of metabolic reprogramming and redox adaptive mechanisms.
From a therapeutic point of view, antioxidants have been found to be useful as chemopreventive agents, while oxidants may function as chemotherapeutics. Furthermore, natural compounds may act as adjuvants capable of reducing the side effects of conventional therapies, overcoming therapy resistance, and improving the survival rate of melanoma patients.
Based on these considerations, this Special Issue is dedicated to original articles and reviews focused on identifying novel redox sensitive targets to counteract melanoma progression and therapeutic resistance. Furthermore, contributions dealing with innovative experimental methods aimed at better understanding melanoma biology, as well as precision medicine approaches employing the combination of the conventional therapy with a redox-centered targeted therapy, are welcome.
Prof. Dr. Cinzia Domenicotti
Dr. Barbara Marengo
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antioxidants is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- melanoma
- redox homeostasis
- ROS
- antioxidants
- therapy resistance
- cancer metabolism
- mitochondria
- epigenetic changes
- innovative therapeutic and experimental approaches
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
